Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Barton

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|October 31, 2003
Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemiaJames C Barton
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Deferasirox NovartisJames C Barton
Drugs|March 28, 2007
Optimal management strategies for chronic iron overloadJames C Barton
Idrugs : the Investigational Drugs Journal|March 29, 2007
Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disordersJames C Barton
Journal of the American Academy of Dermatology|September 1, 2004
Angioedema associated with imiquimodJames C Barton
The Lancet. Haematology|December 3, 2017
Should we treat individuals homozygous for HFE p.Cys282Tyr with ferritin 300-1000 μg/L?James C Barton
Current Gastroenterology Reports|March 6, 2007
Chelation therapy for iron overloadJames C Barton
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Deferitrin for iron overload disordersJames C Barton
The American Journal of the Medical Sciences|October 26, 2013
Hemochromatosis and iron overload: from bench to clinicJames C Barton
Obesity Surgery|December 18, 2004
Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three casesJames C Barton
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|October 31, 2003
Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemiaJames C Barton
Current Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Deferasirox NovartisJames C Barton
Drugs|March 28, 2007
Optimal management strategies for chronic iron overloadJames C Barton
Idrugs : the Investigational Drugs Journal|March 29, 2007
Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disordersJames C Barton
Journal of the American Academy of Dermatology|September 1, 2004
Angioedema associated with imiquimodJames C Barton
The Lancet. Haematology|December 3, 2017
Should we treat individuals homozygous for HFE p.Cys282Tyr with ferritin 300-1000 μg/L?James C Barton
Current Gastroenterology Reports|March 6, 2007
Chelation therapy for iron overloadJames C Barton
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Deferitrin for iron overload disordersJames C Barton
The American Journal of the Medical Sciences|October 26, 2013
Hemochromatosis and iron overload: from bench to clinicJames C Barton
Obesity Surgery|December 18, 2004
Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three casesJames C Barton
Pageof 18